KEFUROX Drug Patent Profile
✉ Email this page to a colleague
When do Kefurox patents expire, and what generic alternatives are available?
Kefurox is a drug marketed by Acs Dobfar and Lilly and is included in three NDAs.
The generic ingredient in KEFUROX is cefuroxime sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kefurox
A generic version of KEFUROX was approved as cefuroxime sodium by ACS DOBFAR SPA on May 30th, 1997.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KEFUROX?
- What are the global sales for KEFUROX?
- What is Average Wholesale Price for KEFUROX?
Summary for KEFUROX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Patent Applications: | 561 |
| DailyMed Link: | KEFUROX at DailyMed |
US Patents and Regulatory Information for KEFUROX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | KEFUROX | cefuroxime sodium | INJECTABLE;INJECTION | 062591-002 | Jan 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | KEFUROX IN PLASTIC CONTAINER | cefuroxime sodium | INJECTABLE;INTRAVENOUS | 062590-001 | Jan 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acs Dobfar | KEFUROX | cefuroxime sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 062591-001 | Jan 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acs Dobfar | KEFUROX | cefuroxime sodium | INJECTABLE;INJECTION | 062591-003 | Dec 17, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
